Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D S Freestone

Showing results (11-20 of 53) with videos related to

Pageof 6
Sort By:
Postgraduate Medical Journal|July 1, 1972
General review of clinical trials of rubella vaccinesD S Freestone
Developments in Biological Standardization|January 1, 1979
Problems in the investigation of adverse reactionsD S Freestone
Antiviral Research|December 1, 1985
The need for new antiviral agentsD S Freestone
Progress in Brain Research|January 1, 1983
Interferon in acute and chronic viral infectionsD Brigden, D S Freestone
BMJ (Clinical Research Ed.)|April 24, 1993
Inappropriate publication of trial results and potential for allegations of illegal share dealingD S Freestone, H Mitchell
British Medical Journal|February 25, 1978
Duration of immunity conferred by rubella vaccinesD S Freestone, S K Hasell
Lancet (London, England)|October 9, 1976
Preclinical data supporting first clinical trials of new inactivated vaccinesD S Freestone, P A Knight
Lancet (London, England)|August 14, 1971
Risk of early post-partum pregnancy in context of post-partum vaccination against rubellaJ A Baldwin, D S Freestone
The Practitioner|December 1, 1973
Rubella vaccination in young women attending a family planning clinicJ M Tattersall, D S Freestone
The Journal of Hygiene|December 1, 1975
Persistence of antibody induced by rubella vaccine (Wistar RA 27/3 strain) after six yearsI B Hillary, D S Freestone
Pageof 6

Showing results (11-20 of 53) with videos related to

Sort By:
Pageof 6
Postgraduate Medical Journal|July 1, 1972
General review of clinical trials of rubella vaccinesD S Freestone
Developments in Biological Standardization|January 1, 1979
Problems in the investigation of adverse reactionsD S Freestone
Antiviral Research|December 1, 1985
The need for new antiviral agentsD S Freestone
Progress in Brain Research|January 1, 1983
Interferon in acute and chronic viral infectionsD Brigden, D S Freestone
BMJ (Clinical Research Ed.)|April 24, 1993
Inappropriate publication of trial results and potential for allegations of illegal share dealingD S Freestone, H Mitchell
British Medical Journal|February 25, 1978
Duration of immunity conferred by rubella vaccinesD S Freestone, S K Hasell
Lancet (London, England)|October 9, 1976
Preclinical data supporting first clinical trials of new inactivated vaccinesD S Freestone, P A Knight
Lancet (London, England)|August 14, 1971
Risk of early post-partum pregnancy in context of post-partum vaccination against rubellaJ A Baldwin, D S Freestone
The Practitioner|December 1, 1973
Rubella vaccination in young women attending a family planning clinicJ M Tattersall, D S Freestone
The Journal of Hygiene|December 1, 1975
Persistence of antibody induced by rubella vaccine (Wistar RA 27/3 strain) after six yearsI B Hillary, D S Freestone
Pageof 6